لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Wessel RE; Department of Biomedical Engineering, University of Virginia (UVA) School of Medicine, Charlottesville, Virginia 22908., Ageeb N; Department of Biology, UVA, Charlottesville, Virginia 22908., Obeid JM; Department of Thoracic Surgery, Temple University Hospital, Philadelphia, Pennsylvania 19140., Mauldin I; Department of Surgery, UVA School of Medicine, Charlottesville, Virginia 22908., Goundry KA; Department of Biomedical Engineering, University of Virginia (UVA) School of Medicine, Charlottesville, Virginia 22908., Hanson GF; Department of Biomedical Engineering, University of Virginia (UVA) School of Medicine, Charlottesville, Virginia 22908., Hossain M; Beirne B. Carter Center for Immunology Research, UVA School of Medicine, Charlottesville, Virginia 22908., Lehman C; Beirne B. Carter Center for Immunology Research, UVA School of Medicine, Charlottesville, Virginia 22908., Gentzler RD; Department of Medicine, Hematology and Oncology, UVA School of Medicine, Charlottesville, Virginia 22908., Wages NA; Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia 23298-0032., Slingluff CL Jr; Department of Surgery, UVA School of Medicine, Charlottesville, Virginia 22908., Bullock TNJ; Beirne B. Carter Center for Immunology Research, UVA School of Medicine, Charlottesville, Virginia 22908.; Department of Pathology, UVA School of Medicine, Charlottesville, Virginia 22908., Dolatshahi S; Department of Biomedical Engineering, University of Virginia (UVA) School of Medicine, Charlottesville, Virginia 22908.; Beirne B. Carter Center for Immunology Research, UVA School of Medicine, Charlottesville, Virginia 22908., Brown MG; Beirne B. Carter Center for Immunology Research, UVA School of Medicine, Charlottesville, Virginia 22908.; Department of Medicine, Nephrology, UVA School of Medicine, Charlottesville, Virginia 22908.; Center for Immunity, Inflammation and Regenerative Medicine, UVA School of Medicine, Charlottesville, Virginia 22908.; Department of Microbiology, Immunology and Cancer Biology, UVA School of Medicine, Charlottesville, Virginia 22908.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 25. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article; Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Gentzler RD; Department of Medicine, Division of Hematology/Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA., Mohindra NA; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Jalal SI; Department of Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA., Reckamp KL; Department of Medicine, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Hall RD; Department of Medicine, Division of Hematology/Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA., Hanna NH; Department of Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA., Chae YK; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Koczywas M; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Helenowski IB; Department of Preventive Medicine, Northwestern University, Chicago, IL, USA., Patel JD; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.

المصدر: The oncologist [Oncologist] 2024 Jan 05; Vol. 29 (1), pp. 47-56.

نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/pathology , Carcinoma, Squamous Cell*/drug therapy, Adult ; Humans ; Carboplatin/pharmacology ; Carboplatin/therapeutic use ; B7-H1 Antigen ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Paclitaxel

المؤلفون: Young P; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA 22903, USA., Elghawy O; School of Medicine, University of Virginia, Charlottesville, VA 22903, USA., Mock J; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA 22903, USA., Wynter E; Department of Medicine, University of Virginia, Charlottesville, VA 22903, USA., Gentzler RD; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA 22903, USA., Martin LW; Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA 22903, USA., Novicoff W; Department of Public Health Sciences and Orthopedic Surgery, University of Virginia, Charlottesville, VA 22903, USA., Hall R; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA 22903, USA.

المصدر: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jan 03; Vol. 31 (1), pp. 260-273. Date of Electronic Publication: 2024 Jan 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/drug therapy , Opioid-Related Disorders*, Humans ; Analgesics, Opioid/therapeutic use ; Immune Checkpoint Inhibitors ; Duration of Therapy

المؤلفون: Passaro A; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: antonio.passaro@ieo.it., Wang J; Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Wang Y; Department of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China., Lee SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Melosky B; British Columbia Cancer Agency, Vancouver, Canada., Shih JY; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan., Wang J; Fudan University Shanghai Cancer Center, Shanghai, China., Azuma K; Kurume University School of Medicine, Kurume, Japan., Juan-Vidal O; Hospital Universitari i Politécnic La Fe, Valencia, Spain., Cobo M; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Girard N; Institut Curie, Institut du Thorax Curie-Montsouris, Paris, France; Paris Saclay University, UVSQ, Versailles, France., Cortot AB; University of Lille, CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France., Califano R; Department of Medical Oncology, Christie NHS Foundation Trust and Division of Cancer Sciences, The University of Manchester, Manchester, UK., Cappuzzo F; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Owen S; Department of Medical Oncology, McGill University Health Centre, Montreal, Quebec, Canada., Popat S; Royal Marsden Hospital NHS Foundation Trust and The Institute of Cancer Research, London, UK., Tan JL; Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Salinas J; Centro de Especialidades Medicas Ambulatorias e Investigación Clínica, Córdoba, Argentina., Tomasini P; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille University, Marseille, France., Gentzler RD; Hematology/Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA., William WN Jr; Centro Oncológico BP, Beneficência Portuguesa de São Paulo, and Grupo Oncoclínicas, São Paulo, Brazil., Reckamp KL; Cedars-Sinai Medical Center, Los Angeles, USA., Takahashi T; Division of Thoracic Oncology, Shizuoka Cancer Center, Nagaizumi, Japan., Ganguly S; Tata Medical Center, Kolkata, India., Kowalski DM; Department of Lung Cancer and Thoracic Tumours, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Bearz A; Medical Oncology, Centro di Riferimento Oncologico-CRO, Aviano, Italy., MacKean M; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Barala P; Janssen Research & Development, Spring House, PA, USA., Bourla AB; Janssen Research & Development, Raritan, NJ, USA., Girvin A; Janssen Research & Development, Spring House, PA, USA., Greger J; Janssen Research & Development, Spring House, PA, USA., Millington D; Janssen Research & Development, San Diego, CA, USA., Withelder M; Janssen Research & Development, Spring House, PA, USA., Xie J; Janssen Research & Development, Raritan, NJ, USA., Sun T; Janssen Research & Development, Raritan, NJ, USA., Shah S; Janssen Research & Development, Spring House, PA, USA., Diorio B; Janssen Research & Development, Raritan, NJ, USA., Knoblauch RE; Janssen Research & Development, Spring House, PA, USA., Bauml JM; Janssen Research & Development, Spring House, PA, USA., Campelo RG; University Hospital A Coruña, A Coruña, Spain., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.

مؤلفون مشاركون: MARIPOSA-2 Investigators

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jan; Vol. 35 (1), pp. 77-90. Date of Electronic Publication: 2023 Oct 23.

نوع المنشور: Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Acrylamides* , Aniline Compounds* , Antibodies, Bispecific* , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Indoles* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Morpholines* , Pyrazoles* , Pyrimidines*, Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carboplatin/adverse effects ; Disease Progression ; ErbB Receptors/genetics ; Mutation ; Protein Kinase Inhibitors/therapeutic use

المؤلفون: Gentzler RD; Division of Hematology/Oncology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA., Villaruz LC; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh Medical Center-Hillman Cancer Center, Pittsburgh, PA, USA., Rhee JC; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh Medical Center-Hillman Cancer Center, Pittsburgh, PA, USA., Horton B; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA., Mock J; Division of Hematology/Oncology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA., Hanley M; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA., Kim K; Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Rudek MA; Department of Oncology and Medicine, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Phelps MA; Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Carducci MA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Piekarz R; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA., Park KS; Department of Microbiology, Immunology, and Cancer Biology, School of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA., Bullock TN; Department of Pathology, University of Virginia Cancer Center, Charlottesville, VA, USA., Rudin CM; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

المصدر: The oncologist [Oncologist] 2023 Nov 02; Vol. 28 (11), pp. 1007-e1107.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Small Cell Lung Carcinoma*/drug therapy , Lung Neoplasms*/drug therapy , Neutropenia*/chemically induced , Thrombocytopenia*/chemically induced , Anemia*/chemically induced, Humans ; Male ; Female ; Etoposide ; Carboplatin ; Bayes Theorem ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

المؤلفون: Fadul CE; Division of Neuro-Oncology, Department of Neurology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA., Sarai G; Division of Neuro-Oncology, Department of Neurology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA., Bovi JA; Department of Radiation Oncology, The Medical College of Wisconsin, Milwaukee, WI 53222, USA., Thomas AA; Department of Neurological Sciences, University of Vermont Larner College of Medicine, Burlington, VT 05405, USA., Novicoff W; Department of Public Health Sciences and Orthopedic Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, USA., Anderson R; Population Sciences, University of Virginia School of Medicine, Charlottesville, VA 22908, USA., Amidon RF; Department of Radiation Oncology, The Medical College of Wisconsin, Milwaukee, WI 53222, USA., Schuetz S; Department of Neurological Sciences, University of Vermont Larner College of Medicine, Burlington, VT 05405, USA., Singh R; Division of Hematology and Oncology, University of Vermont Larner College of Medicine, Burlington, VT 05405, USA., Chang A; Department of Neurological Sciences, University of Vermont Larner College of Medicine, Burlington, VT 05405, USA., Gentzler RD; Division of Hematology and Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908, USA., Gaughan EM; Division of Hematology and Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908, USA., Sheehan JP; Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

المصدر: Cancers [Cancers (Basel)] 2023 Jun 20; Vol. 15 (12). Date of Electronic Publication: 2023 Jun 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Shantzer LB; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Dougherty SC; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Bolte F; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Melson JW; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Reed DR; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Lynch AC; Department of Pharmacy, University of Virginia Health System, Charlottesville, VA., Gentzler RD; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Novicoff W; Department of Public Health Sciences and Orthopaedic Surgery, HSC, University of Virginia Health System, Charlottesville, VA., Hall RD; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA. Electronic address: rdh3q@uvahealth.org.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2023 Mar; Vol. 24 (2), pp. e60-e64. Date of Electronic Publication: 2022 Nov 26.

نوع المنشور: Case Reports; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/therapy , Lung Neoplasms*/therapy, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Immunotherapy/adverse effects

المؤلفون: Ardeshir-Larijani F; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Althouse SK; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Leal T; Winship Cancer Institute, Emory University., Feldman LE; University of Illinois Hospital & Health Sciences System, Chicago, IL., Hejleh TA; University of Iowa Hospitals and Clinics, Iowa City, IA., Patel M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Gentzler RD; University of Virginia Cancer Center, Charlottesville, VA., Miller AR; Massachusetts General Hospital, Boston, MA., Hanna NH; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN. Electronic address: nhanna@iu.edu.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2022 Nov; Vol. 23 (7), pp. 578-584. Date of Electronic Publication: 2022 Jul 21.

نوع المنشور: Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung* , Lung Neoplasms* , Neutropenia*/etiology , Sepsis*, Male ; Humans ; Female ; Middle Aged ; Pemetrexed/therapeutic use ; Carboplatin/therapeutic use ; Bevacizumab/therapeutic use ; B7-H1 Antigen ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use